Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activity

Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activity

Abstract Donor T cell activation, proliferation, differentiation, and migration are the major steps involved in graft-versus-host disease (GVHD) development following bone marrow transplantation. Chondroitin sulfate (CS) proteoglycan is a major component of the extracellular matrix and causes immune...

Full description

Bibliographic Details
Main Authors:	Suguru Tamura, Hajime Ishiguro, Tatsuya Suwabe, Takayuki Katagiri, Kaori Cho, Kyoko Fuse, Yasuhiko Shibasaki, Tadahisa Mikami, Takero Shindo, Hiroshi Kitagawa, Michihiro Igarashi, Hirohito Sone, Masayoshi Masuko, Takashi Ushiki
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-40367-3

Similar Items

Hypertrophic pachymeningitis associated with myelodysplastic syndrome
by: Akane Kaihatsu, et al.
Published: (2020-07-01)

P1374: EASIX ASSESSED AT 1 YEAR AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION PREDICTS THE ONSET OF SUBSEQUENT NON-RELAPSE MORTALITY
by: R. Takeda, et al.
Published: (2022-06-01)

Altered sulfation status of FAM20C-dependent chondroitin sulfate is associated with osteosclerotic bone dysplasia
by: Toshiyasu Koike, et al.
Published: (2022-12-01)

Altered microbiota by a high-fat diet accelerates lethal myeloid hematopoiesis associated with systemic SOCS3 deficiency
by: Kaori Cho, et al.
Published: (2021-10-01)

Structural Variation of Chondroitin Sulfate Chains Contributes to the Molecular Heterogeneity of Perineuronal Nets
by: Shinji Miyata, et al.
Published: (2018-02-01)

GVHD TREATMENT
by: Elif BirtaşAteşoğlu
Published: (2021-11-01)

Abnormalities in perineuronal nets and behavior in mice lacking CSGalNAcT1, a key enzyme in chondroitin sulfate synthesis
by: Nozomu Yoshioka, et al.
Published: (2017-10-01)

The thymus in GVHD pathophysiology.
by: Krenger, W, et al.
Published: (2008)

The immunopathology of thymic GVHD.
by: Krenger, W, et al.
Published: (2008)

GVHD Prophylaxis 2020
by: Mahasweta Gooptu, et al.
Published: (2021-04-01)

Milestones in acute GVHD pathophysiology
by: Gerard Socie, et al.
Published: (2022-12-01)

Regulatory T Cells in GVHD Therapy
by: Wen-wen Guo, et al.
Published: (2021-06-01)

Modulation of ATP Production Influences Inorganic Polyphosphate Levels in Non-Athletes’ Platelets at the Resting State
by: Takashi Ushiki, et al.
Published: (2022-09-01)

Strategic analysis of body composition indices and resting platelet ATP levels in professional soccer players for better platelet-rich plasma therapy
by: Takashi Ushiki, et al.
Published: (2023-08-01)

Impact of oral microbiota on pathophysiology of GVHD
by: Akira Yamamoto, et al.
Published: (2023-03-01)

Late onset of oral chronic GVHD
by: Paulo Sérgio da Silva Santos, et al.
Published: (2008-06-01)

Global analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycans.
by: Panpan Yu, et al.
Published: (2013-01-01)

ER stress: an emerging regulator in GVHD development
by: Hee-Jin Choi, et al.
Published: (2023-09-01)

Rearrangement of T Cell genome architecture regulates GVHD
by: Yaping Sun, et al.
Published: (2022-09-01)

Established and Emerging Treatments of Skin GvHD
by: Cornelia S. Link-Rachner, et al.
Published: (2022-02-01)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
by: Shabnam Shokouhi, et al.
Published: (2015-09-01)

Heterologous production of chondroitin
by: Márcia R. Couto, et al.
Published: (2022-03-01)

Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice
by: Nadezhda E. Ustyuzhanina, et al.
Published: (2021-10-01)

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
by: Markey, K, et al.
Published: (2010)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
by: Apperley, J, et al.
Published: (1986)

Separation of GVL from GVHD -location, location, location
by: Takanori Teshima, et al.
Published: (2023-12-01)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
by: Takahide Ara, et al.
Published: (2021-08-01)

Roles of the intestinal microbiota and microbial metabolites in acute GVHD
by: Dandan Lin, et al.
Published: (2021-10-01)

A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate
by: Xiao-Man Fan, et al.
Published: (2022-04-01)

Holothurian Fucosylated Chondroitin Sulfate
by: Vitor H. Pomin
Published: (2014-01-01)

Chondroitin Sulfate Safety and Quality
by: Nicola Volpi
Published: (2019-04-01)

Is chondroitin sulfate effective for osteoarthritis?
by: Valentina Rojas-Briones, et al.
Published: (2017-06-01)

A Coarse-Grained Molecular Model for Glycosaminoglycans: Application to Chondroitin, Chondroitin Sulfate, and Hyaluronic Acid
by: Bathe, Mark, et al.
Published: (2014)

Chondroitin sulfate synthase-2 is necessary for chain extension of chondroitin sulfate but not critical for skeletal development.
by: Hiroyasu Ogawa, et al.
Published: (2012-01-01)

The significance of M1‐polarized CD163+ macrophages in acute graft‐versus‐host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions
by: Yusuke Muto, et al.
Published: (2023-08-01)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
by: Ryo Hanaki, et al.
Published: (2021-12-01)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
by: Irina Kostareva, et al.
Published: (2022-09-01)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
by: Giancarlo Fatobene, et al.
Published: (2022-07-01)

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective
by: Benjamin Watkins, et al.
Published: (2022-11-01)

Progress of cGVHD pathogenesis from the perspective of B cells
by: Xiaoping Li, et al.
Published: (2019-08-01)